This inventor holds 1 USPTO granted patent. Top assignees: Bioventures, LLC, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: The Innovations of Robert Shmookler Reis
Introduction
Robert Shmookler Reis is an accomplished inventor based in Little Rock, Arkansas. He has made significant contributions to the field of neurodegeneration through his innovative research and patent. His work focuses on methods to protect against neurodegenerative diseases, showcasing his commitment to advancing medical science.
Latest Patents
Robert Shmookler Reis holds a patent for "Methods of protecting against neurodegeneration." This patent provides a method for preventing or reducing protein aggregates using combretastatin-A4 (CA4) or an analog thereof. The disclosure also outlines methods for reducing the risk, delaying the onset, or reversing the signs of neurodegenerative diseases. The combretastatin-A4 (CA4) or its analogs may bind to glial fibrillary acidic protein (GFAP), offering a promising avenue for treatment.
Career Highlights
Throughout his career, Reis has worked with notable organizations, including Bioventures, LLC and the United States Government as represented by the Department of Veterans Affairs. His experience in these institutions has allowed him to contribute to significant advancements in medical research and innovation.
Collaborations
Reis has collaborated with esteemed colleagues such as Peter Crooks and Srinivas Ayyadevara. These partnerships have further enriched his research and expanded the impact of his work in the field of neurodegeneration.
Conclusion
Robert Shmookler Reis is a notable inventor whose work in neurodegeneration has the potential to change lives. His innovative methods and collaborations highlight the importance of research in combating age-progressive diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile